1. Home
  2. CMMB vs SVT Comparison

CMMB vs SVT Comparison

Compare CMMB & SVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMMB
  • SVT
  • Stock Information
  • Founded
  • CMMB 2004
  • SVT 1959
  • Country
  • CMMB Israel
  • SVT United States
  • Employees
  • CMMB N/A
  • SVT N/A
  • Industry
  • CMMB Biotechnology: Pharmaceutical Preparations
  • SVT Industrial Machinery/Components
  • Sector
  • CMMB Health Care
  • SVT Consumer Discretionary
  • Exchange
  • CMMB Nasdaq
  • SVT Nasdaq
  • Market Cap
  • CMMB 23.0M
  • SVT 27.2M
  • IPO Year
  • CMMB N/A
  • SVT N/A
  • Fundamental
  • Price
  • CMMB $1.21
  • SVT $10.50
  • Analyst Decision
  • CMMB Strong Buy
  • SVT
  • Analyst Count
  • CMMB 2
  • SVT 0
  • Target Price
  • CMMB $9.00
  • SVT N/A
  • AVG Volume (30 Days)
  • CMMB 89.3K
  • SVT 6.2K
  • Earning Date
  • CMMB 05-27-2025
  • SVT 05-09-2025
  • Dividend Yield
  • CMMB N/A
  • SVT N/A
  • EPS Growth
  • CMMB N/A
  • SVT N/A
  • EPS
  • CMMB N/A
  • SVT N/A
  • Revenue
  • CMMB N/A
  • SVT $46,174,000.00
  • Revenue This Year
  • CMMB N/A
  • SVT N/A
  • Revenue Next Year
  • CMMB N/A
  • SVT N/A
  • P/E Ratio
  • CMMB N/A
  • SVT N/A
  • Revenue Growth
  • CMMB N/A
  • SVT 2.58
  • 52 Week Low
  • CMMB $0.60
  • SVT $9.67
  • 52 Week High
  • CMMB $2.55
  • SVT $13.67
  • Technical
  • Relative Strength Index (RSI)
  • CMMB 46.51
  • SVT 48.91
  • Support Level
  • CMMB $1.15
  • SVT $10.26
  • Resistance Level
  • CMMB $1.31
  • SVT $10.68
  • Average True Range (ATR)
  • CMMB 0.09
  • SVT 0.17
  • MACD
  • CMMB -0.00
  • SVT -0.01
  • Stochastic Oscillator
  • CMMB 22.58
  • SVT 34.78

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.

About SVT Servotronics Inc.

Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users. Geographically, the company generates the majority of its revenue from the Domestic market.

Share on Social Networks: